Digoxin affects potassium homeostasis during exercise in patients with heart failure
- PMID: 7796444
Digoxin affects potassium homeostasis during exercise in patients with heart failure
Abstract
Objective: The aim was to evaluate whether digitalisation of heart failure patients affects extrarenal potassium handling during and following exercise, and to assess digoxin receptor occupancy in human skeletal muscle in vivo.
Methods: In a paired study of before versus after digitalisation, 10 patients with congestive heart failure underwent identical exercise sessions consisting of three bouts of increasing work rates, 41-93 W, on a cycle ergometer. The final bouts were followed by exercise to exhaustion. The femoral vessels and brachial artery were catheterised. Arterial blood pressure, heart rate, leg blood flow, cardiac output, plasma potassium, haemoglobin, pH, and skeletal muscle receptor occupancy with digoxin in biopsies were determined.
Results: Occupancy of skeletal muscle Na/K-ATPase with digoxin was 9% (P < 0.05). Following digitalisation femoral venous plasma potassium increased by 0.2-0.3 mmol.litre-1 (P < 0.05) at work rates of 69 W, 93 W, and at exhaustion, as well as during the first 3 min of recovery. Following digitalisation the femoral venoarterial difference in plasma potassium increased by 50-100% (P < 0.05) during exercise, and decreased by 66-75% (P < 0.05) during early recovery. Total loss of potassium from the leg increased by 138%. The effects of digitalisation on plasma potassium were not the outcome of changes in haemodynamics, because cardiac output and leg blood flow increased by up to 13% and 19% (P < 0.05), nor was it the outcome of changes in haemoconcentration or pH.
Conclusions: Extrarenal potassium handling is altered as a result of digoxin treatment. This is likely to reflect a reduced capacity of skeletal muscle Na/K-ATPase for active potassium uptake because of inhibition by digoxin, adding to the reduction of skeletal muscle Na/K-ATPase concentration induced by heart failure per se. In heart failure patients, improved haemodynamics induced by digoxin may, however, increase the capacity for physical conditioning. Thus the impairment of extrarenal potassium homeostasis by heart failure and digoxin treatment may be counterbalanced by training.
Similar articles
-
[Mechanisms facilitating oxygen delivery during exercise in patients with chronic heart failure].Cardiologia. 1997 Jul;42(7):743-50. Cardiologia. 1997. PMID: 9270180 Italian.
-
Muscle Na,K-pump dysfunction may expose the heart to dangerous K levels during exercise.Can J Sport Sci. 1991 Mar;16(1):33-9. Can J Sport Sci. 1991. PMID: 1645213
-
Effect of high-intensity intermittent training on lactate and H+ release from human skeletal muscle.Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E245-51. doi: 10.1152/ajpendo.00303.2003. Epub 2003 Oct 14. Am J Physiol Endocrinol Metab. 2004. PMID: 14559724
-
Human myocardial and skeletal muscular Na,K-ATPase in relation to digoxin therapy of heart failure.Dan Med Bull. 1997 Nov;44(5):499-521. Dan Med Bull. 1997. PMID: 9408736 Review. No abstract available.
-
Hormonal and pharmacological modification of plasma potassium homeostasis.Fundam Clin Pharmacol. 2010 Oct;24(5):595-605. doi: 10.1111/j.1472-8206.2010.00859.x. Fundam Clin Pharmacol. 2010. PMID: 20618871 Review.
Cited by
-
Oral digoxin effects on exercise performance, K+ regulation and skeletal muscle Na+ ,K+ -ATPase in healthy humans.J Physiol. 2022 Aug;600(16):3749-3774. doi: 10.1113/JP283017. Epub 2022 Aug 2. J Physiol. 2022. PMID: 35837833 Free PMC article. Clinical Trial.
-
Myocardial Na,K-ATPase: Clinical aspects.Exp Clin Cardiol. 2003 Fall;8(3):131-3. Exp Clin Cardiol. 2003. PMID: 19641704 Free PMC article.
-
Digoxin and exercise effects on skeletal muscle Na+,K+-ATPase isoform gene expression in healthy humans.Exp Physiol. 2024 Nov;109(11):1909-1921. doi: 10.1113/EP091962. Epub 2024 Sep 2. Exp Physiol. 2024. PMID: 39222217 Free PMC article. Clinical Trial.
-
The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.Clin Pharmacokinet. 2006;45(5):433-48. doi: 10.2165/00003088-200645050-00001. Clin Pharmacokinet. 2006. PMID: 16640451 Review.
-
Human myocardial Na,K-ATPase concentration in heart failure.Mol Cell Biochem. 1996 Oct-Nov;163-164:277-83. doi: 10.1007/BF00408668. Mol Cell Biochem. 1996. PMID: 8974067 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical